Biography
Carin A. Uyl-de Groot studied Health Care Policy and Management at the ÃÀÅ®¸£ÀûµçÓ°ÔºÎçÒ¹. From March 1990 onwards she is working at the institute for Medical Technology Assessment/Department of Health Care Policy and Management at the Erasmus Medical Centre Rotterdam. Her research activities are mainly focused on cost-effectiveness analyses of cancer treatments. Quality of life studies are an integral part of these studies. From 1994 she is program leader of cancer studies. Her main interest consists of diagnostics and therapeutic technologies, economic studies linked to clinical studies, modelling studies, cost studies, quality of life studies, methodological issues and implementation studies particularly in the cancer field. She got her PhD in 1995. Since March 2000 she is director of the institute for Medical Technology Assessment. Since November 2005 she has been appointed professor of health technology assessment at the VU University Medical Center in Amsterdam.
Erasmus School of Health Policy & Management
- uyl@eshpm.eur.nl
More information
Work
- Carlos Antonio Godoy Junior, Lucia Peñarrubia-San-Florencio, Silvia Ricart, Sergi Navarro VilarrubÃ, Maria Rimblas Roure, Cristina Ruiz-Herguido, Arnau Valls-Esteve, Luis Pilli, Carin Uyl-de Groot, William Ken Redekop & Welmoed Kirsten van Deen (2026) - - Journal of Palliative Care - doi: -
- Dianne Bosch, Kim J.M. van der Velden, Aart Beeker, Hendrik P. van den Berg, André M. Bergman, Maarten J. van der Doelen, Alfons J.M. van den Eertwegh, Mathijs P. Hendriks, Thomas M.A. Kerkhofs, Addy C.M. van de Luijtgaarden, Niven Mehra, Reindert J.A. van Moorselaar, Metin Tascilar, Walter L. Vervenne, Nir I. Weijl, Carin A. Uyl-de Groot, Peter F.A. Mulders, Malou C.P. Kuppen & Inge M. van Oort (2026) - - Drugs - Real World Outcomes, 13 (2), 183-192 - doi: -
- Diego Larrotta-Castillo, Yi Hsuan Chen, Luuk van der Hoek, Bram Ramaekers, Brenda Leeneman, Carin A. Uyl-De Groot, Johannes A. Langendijk & Hedwig M. Blommestein (2026) - - Radiotherapy and Oncology, 219 - doi: -
- Leonarda Bremmers, Leona Hakkaart - van Roijen, Carin de Groot & Isabelle Fabbricotti (2026) - - Community Mental Health Journal - doi: -
- Axel Glasmacher, Kim Lyerly, Birgit Wolf, Pio Zapella, Lidia Zielinska, Emma Clark, Murielle Mauer, Bruno Paiva, Anja Schiel, Fergus Sweeney, Carin A. Uyl-de Groot, Marie von Lilienfeld-Toal & Jaap Verweij (2026) - - Therapeutic Innovation and Regulatory Science, 60 (3), 688-702 - doi: -
- Carlos A. Godoy Junior, Bart Jan Boverhof, Maureen P.M.H. Rutten-van Mölken, Lieke Bijleveld, Bianca Westhuis, Carin Uyl de Groot & Ken Redekop (2026) - - Value in Health, 29 (5), 896-904 - doi: -
- Nicolas S.H. Xander, Maureen P.M.H. Rutten-Van Mölken, Louis Bertin, Nenad Miljković & Carin A. Uyl-De Groot (2026) - - Health Economics, Policy and Law - doi: -
- Katharina Brück, Richard P. Meijer, Joost L. Boormans, , Lambertus A. Kiemeney, J. Alfred Witjes, Lisa M.C. van Hoogstraten, Michiel S. van der Heijden, A. Rogier Donders, Martine Franckena, Carin A. Uyl-de Groot, Annemarie M. Leliveld-Kors, Katja K.H. Aben & Maarten C.C.M. Hulshof (2026) - - Tijdschrift voor Urologie, 16 (2-3), 59–67 - doi: -
- Carin A. Uyl-de Groot, Nicolas S.H. Xander, Tom Belleman, Emily A. Burger, Robin Doeswijk, Isabelle Durand-Zaleski, Benjamin P. Geisler, Oliver Groene, Anne Hendrickx, Pia S. Henkel, Renaud Heine, Mirjana Huić, Mauro Melli, Kate Morgan, Monica Racovița, Gauthier Quinonez, Maureen P.M.H. Rutten-van Mölken, Tomáš Tesař, Frederick W. Thielen, Peter Schneider, Yancy S. Wu, Maximilian Salcher-Konrad & Eline Aas (2026) - - Health Policy and Technology, 15 (2) - doi: -
- Nicolas Xander, Tom Belleman, Maximilian Salcher-Konrad, Anne Hendrickx, Jeffrey Chen, Anne-Sophie Klein Gebbink, Peter Schneider, Kate Morgan, Oliver Groene, Isabelle Durand-Zaleski, Frederick Thielen & Carin Uyl-de Groot (2026) - - European Journal of Health Economics, 27 (2), 479-508 - doi: -
- Carin Uyl - de Groot, Ken Redekop, Amir Ansaripour, K. Zendehdel, N. Tadayon & F. Sadeghi (2016) - Use of data-mining to perform a real world cost analysis of HER2-positive breast cancer in Iran
Cie Beoordeling Oncologische Middelen
- Start date approval
- July 2025
- End date approval
- July 2028
- Place
- UTRECHT
Gezondheidsraad
- Start date approval
- July 2025
- End date approval
- July 2028
- Place
- DEN HAAG
bestuurslid CPO, Erasmus Medisch Centrum
- Start date approval
- July 2025
- End date approval
- July 2028
- Place
- ONBEKEND
- Level
- master
- Year Level
- master
- Year
- 2025
- Course Code
- GW4555M
- Year Level
- master, master
- Year
- 2025
- Course Code
- GW4592M
